中年期に im を提示する小児的状態.

Smell testing: an additional tool for identification of adult Refsum's disease.

Journal of neurology, neurosurgery, and psychiatry·2004

Hearing loss in adult Refsum's disease.

Clinical otolaryngology and allied sciences·2003

Identification of genetic heterogeneity in Refsum's disease.

European journal of human genetics : EJHG·2000

Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin.

Epilepsia·1999

Transport of phytanic acid on lipoproteins in Refsum disease.

Journal of inherited metabolic disease·1999

Influence of plasma phytanic acid levels in Refsum's disease on the behaviour of the erythrocyte membrane sodium-lithium countertransporter.

European journal of clinical investigation·1998

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Correction: Micheli et al. Phaseolus vulgaris L. Extract: Alpha-Amylase Inhibition Against Metabolic Syndrome in Mice. Nutrients 2019, 11, 1778.

Nutrients·2026

Assessment of treatment response in recurrent medulloblastoma using craniospinal MRI.

European journal of radiology·2026

First records of the genus Macrobathra Meyrick, 1883 (Lepidoptera: Cosmopterigidae) from Taiwan, with description of a new species and two newly recorded species.

Zootaxa·2026

A new Lagria Fabricius, 1775 from Xizang, China, with a checklist of Lagriini in Mêdog County (Coleoptera: Tenebrionidae: Lagriinae).

Zootaxa·2026

Review of the genus Micraspis Chevrolat, 1836 (Coleoptera: Coccinellidae) from China and Laos, with description of three new species.

Zootaxa·2026

A prospective observational within-person MRI morphometric study comparing ictal and interictal brain volumes in status migrainosus.

Neuroimage. Reports·2026

関連する実験動画

中年期に im を提示する小児的状態.

関連する概念動画

Smell testing: an additional tool for identification of adult Refsum's disease.

Hearing loss in adult Refsum's disease.

Identification of genetic heterogeneity in Refsum's disease.

Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin.

Transport of phytanic acid on lipoproteins in Refsum disease.

Influence of plasma phytanic acid levels in Refsum's disease on the behaviour of the erythrocyte membrane sodium-lithium countertransporter.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Correction: Micheli et al. <i>Phaseolus vulgaris</i> L. Extract: Alpha-Amylase Inhibition Against Metabolic Syndrome in Mice. <i>Nutrients</i> 2019, <i>11</i>, 1778.

Assessment of treatment response in recurrent medulloblastoma using craniospinal MRI.

<b>First records of the genus <i>Macrobathra</i> Meyrick, 1883 (Lepidoptera: Cosmopterigidae) from Taiwan, with description of a new species and two newly recorded species</b>.

<b>A new <i>Lagria</i> Fabricius, 1775 from Xizang, China, with a checklist of Lagriini in Mêdog County (Coleoptera: Tenebrionidae: Lagriinae)</b>.

<b>Review of the genus <i>Micraspis</i> Chevrolat, 1836 (Coleoptera: Coccinellidae) from China and Laos, with description of three new species</b>.

A prospective observational within-person MRI morphometric study comparing ictal and interictal brain volumes in status migrainosus.

関連する実験動画

中年期に im を提示する小児的状態.

関連する概念動画

関連記事